Back to search
FDAFDA · Food and drugs·Recall number D-0667-2017

Lumigan (bimatoprost ophthalmic solution) 0.01%, 7.5 mL bottle, Rx only, Allergan Irvine, CA 92612, NDC 0023-3205-08.

Published April 19, 2017 · Recall initiated: March 16, 2017

Summary

FDA records drug Class III recall D-0667-2017, published April 19, 2017 and initiated March 16, 2017. Recalling firm: Allergan Sales, LLC; Status: Terminated; Reported quantity: 56,878 bottles; Lot: Lot #: 92577, Exp. JUN 2018. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if LUMIGAN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LUMIGAN
Manufacturer
Allergan Sales, LLC
Distributor
Nationwide in the US
Lot
Lot #: 92577, Exp. JUN 2018
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lumigan (bimatoprost ophthalmic solution) 0.01%, 7.5 mL bottle, Rx only, Allergan Irvine, CA 92612, NDC 0023-3205-08. recalled?

Yes. FDA published recall D-0667-2017 on April 19, 2017. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LUMIGAN.